These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 32638014

  • 1. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells.
    He J, Peng H, Wang M, Liu Y, Guo X, Wang B, Dai L, Cheng X, Meng Z, Yuan L, Cai F, Tang Y.
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug 05; 52(8):810-820. PubMed ID: 32638014
    [Abstract] [Full Text] [Related]

  • 2. Role of PI3K/Akt/mTOR pathway-mediated macrophage autophagy in affecting the phenotype transformation of lung fibroblasts induced by silica dust exposure.
    DU Y, Huang F, Guan L, Zeng M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug 28; 48(8):1152-1162. PubMed ID: 37875355
    [Abstract] [Full Text] [Related]

  • 3. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
    Liu MW, Su MX, Tang DY, Hao L, Xun XH, Huang YQ.
    BMC Pulm Med; 2019 Feb 11; 19(1):35. PubMed ID: 30744607
    [Abstract] [Full Text] [Related]

  • 4. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
    Zhang XR, Wang SY, Sun W, Wei C.
    Mol Med Rep; 2018 Sep 11; 18(3):3429-3436. PubMed ID: 30066879
    [Abstract] [Full Text] [Related]

  • 5. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H, Lyu X, Liu Y, Peng N, Tan S, Dong L, Zhang X.
    Life Sci; 2023 Dec 01; 334():122218. PubMed ID: 37918625
    [Abstract] [Full Text] [Related]

  • 6. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L, Yang M, Tian X, Zhao P, Mei X, Bai Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov 01; 34(11):1161-1166. PubMed ID: 36567559
    [Abstract] [Full Text] [Related]

  • 7. Thy-1 depletion and integrin β3 upregulation-mediated PI3K-Akt-mTOR pathway activation inhibits lung fibroblast autophagy in lipopolysaccharide-induced pulmonary fibrosis.
    Wan H, Xie T, Xu Q, Hu X, Xing S, Yang H, Gao Y, He Z.
    Lab Invest; 2019 Nov 01; 99(11):1636-1649. PubMed ID: 31249375
    [Abstract] [Full Text] [Related]

  • 8. Autophagy participates in isoliquiritigenin-induced melanin degradation in human epidermal keratinocytes through PI3K/AKT/mTOR signaling.
    Yang Z, Zeng B, Pan Y, Huang P, Wang C.
    Biomed Pharmacother; 2018 Jan 01; 97():248-254. PubMed ID: 29091873
    [Abstract] [Full Text] [Related]

  • 9. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S, Zhuang Y, Shan B, Danchuk S, Luo F, Korfei M, Guenther A, Lasky JA.
    PLoS One; 2017 Jan 01; 12(10):e0186615. PubMed ID: 29045477
    [Abstract] [Full Text] [Related]

  • 10. Leptin promotes pulmonary fibrosis development by inhibiting autophagy via PI3K/Akt/mTOR pathway.
    Gui X, Chen H, Cai H, Sun L, Gu L.
    Biochem Biophys Res Commun; 2018 Apr 06; 498(3):660-666. PubMed ID: 29524411
    [Abstract] [Full Text] [Related]

  • 11. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.
    Lu Y, Zhong W, Liu Y, Chen W, Zhang J, Zeng Z, Huang H, Qiao Y, Wan X, Meng X, Cai S, Dong H.
    Int Immunopharmacol; 2022 Mar 06; 104():108504. PubMed ID: 35026657
    [Abstract] [Full Text] [Related]

  • 12. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction.
    Dai J, Sun Y, Chen D, Zhang Y, Yan L, Li X, Wang J.
    Eur J Pharmacol; 2019 Dec 01; 864():172724. PubMed ID: 31600493
    [Abstract] [Full Text] [Related]

  • 13. Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis.
    Yu JZ, Ying Y, Liu Y, Sun CB, Dai C, Zhao S, Tian SZ, Peng J, Han NP, Yuan JL, Yan JY, Yang ZS.
    Biomed Pharmacother; 2019 Oct 01; 118():109293. PubMed ID: 31401393
    [Abstract] [Full Text] [Related]

  • 14. ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro.
    Song L, Luo Y, Li S, Hong M, Wang Q, Chi X, Yang C.
    Drug Des Devel Ther; 2020 Oct 01; 14():4363-4376. PubMed ID: 33116421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis.
    Chitra P, Saiprasad G, Manikandan R, Sudhandiran G.
    J Mol Med (Berl); 2015 Sep 01; 93(9):1015-31. PubMed ID: 25877860
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
    Li D, Lu Z, Xu Z, Ji J, Zheng Z, Lin S, Yan T.
    Biosci Rep; 2016 Aug 01; 36(4):. PubMed ID: 27129295
    [Abstract] [Full Text] [Related]

  • 19. Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways.
    Shi W, Fang Y, Jiang Y, Jiang S, Li Y, Li W, Xu M, Aschner M, Liu G.
    Bioengineered; 2021 Dec 01; 12(1):4475-4488. PubMed ID: 34304701
    [Abstract] [Full Text] [Related]

  • 20. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R, Zhang Y, Zang B, Tan L, Jin M.
    J Pharm Pharmacol; 2016 Oct 01; 68(10):1320-30. PubMed ID: 27457091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.